358
On 18/12/2007, a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 519. The active ingredient is Maribavir for prevention of cytomegalovirus (CMV) disease in patients with impaired cell mediated immunity deemed at risk.